Nicoletta Tomasi

Moderate immunohistochemical expression of HER-2 (2+) without HER-2 gene amplification is a negative prognostic factor in early breast cancer.

R. Ponzone, F. Montemurro, V. Rossi, 2012, The oncologist.

Moderate immunohistochemical expression of HER-2 (2+) without HER-2 gene amplification is a negative prognostic factor in early breast cancer.

R. Ponzone, F. Montemurro, V. Rossi, 2012, The oncologist.